Cooke, J.P., P. Tsao, A. Singer, B.Y. Wang, J. Kosck, H. Drexler, 1993. Anti-atherogenic effect of nuts: is the answer NO? Arch Intern Med. 153:896, 899, 902.
In a commentary regarding the Seventh Day Adventist study, the authors highlight the fact that frequent nut consumption reduced the risk of experiencing fatal or nonfatal heart attacks by 50%. A possible explanation for the protective effect may be that nuts are high in arginine, a basic amino acid that is a precursor to nitric oxide (NO). The latter is known to inhibit plaque formation, or atherogenesis, which can lead to heart attacks. Studies have shown that people with hypercholesterolemia have reduced activity of NO. Adding arginine-rich nuts to the diet may help increase NO activity and thereby reduce the risk of heart attacks.
Singh, R.B., S.S. Rastogi, R.Verma, L. Bolaki, R. Singh, 1992. An Indian experiment with nutritional modulation in acute myocardial infarction. Am J Cardiol. 69:879-85.
In a randomized, single-blind intervention trial, 406 patients 24 to 48 hours after acute myocardial infarction (AMI) were assigned to either diet A (204 patients, group A) or B (202 patients, group B) for 6 weeks. At entry to the study, mean age, male sex, risk factors, complications, possible and definite AMI, and drug therapy were comparable between the 2 groups. Dietary adherence to intervention and control diets was checked by questionnaire, and drug therapy by tablet count. Group A received significantly lower calories, a higher percentage of calories from complex carbohydrates, vegetable/fish proteins, polyunsaturated fatty acids, and a higher polyunsaturated/saturated fat ratio diet than did group B (higher total calories and saturated fatty acids). Group A also received less dietary cholesterol, salt and caffeine, and higher soluble dietary fiber, vitamins and minerals than did group B. After 6 weeks, group A had a significant decrease in mean serum total (-20.5 vs -8.6 mg/dl) and low-density lipoprotein (-16.6 vs -6.4 mg/dl) cholesterols, and triglycerides (-15.5 vs -7.6 mg/dl), with no decrease in high-density lipoprotein cholesterol (-1.5 vs -1.3 mg/dl) compared with the initial levels and changes in group B. Group A also had a greater decrease in mean body weight (3.4 vs 1.3 kg) than that of group B.